|

Chinese Alliance for Type 1 Diabetes Multi-center Collaborative Research

RECRUITINGSponsored by Second Xiangya Hospital of Central South University
Actively Recruiting
SponsorSecond Xiangya Hospital of Central South University
Started2016-09
Est. completion2027-09
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT04096794

Summary

The China Alliance for Type 1 Diabetes (CAT1D) is committed to exploring and implementing the model of graded diagnosis and treatment of type 1 diabetes and comprehensive management of outpatient service, carrying out a series of educational activities for patients, and cooperating in the development of multi-center prospective clinical research on type 1 diabetes.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Individuals diagnosed with Type 1 Diabetes according to the 1999 World Health Organization report
* Written informed consent from the patient or family representative;
* Individuals who own smartphone and are capable of using wechat or apps

Exclusion Criteria:

* Non-t1dm patients with autoimmune polyendocrine adenopathy syndrome (APS) are the first disease
* With mental disorders
* Have any other condition or disease that may hamper from compliance with the protocol or complication of the trial

Conditions2

DiabetesType 1 Diabetes Mellitus

Browse More Trials

Diabetes trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.